Loss of the epigenetic mark, 5-Hydroxymethylcytosine, correlates with small cell/nevoid subpopulations and assists in microstaging of human melanoma.
Affiliation
Program in Dermatopathology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MAIssue Date
2015-10-09
Metadata
Show full item recordAbstract
Melanomas in the vertical growth phase (VGP) not infrequently demonstrate cellular heterogeneity. One commonly encountered subpopulation displays small cell/nevoid morphology. Although its significance remains unknown, such subpopulations may pose diagnostic issues when faced with differentiating such changes from associated nevus or mistaking such regions for nevic maturation (pseudomaturation). That 'loss' of the epigenetic biomarker, 5-hydroxymethylcytosine (5-hmC), is a hallmark for melanoma and correlates with virulence prompted us to explore the diagnostic utility and biological implications of 5-hmC immunohistochemistry (IHC) in melanomas with small cell/nevoid subpopulations. Fifty-two cases were included in this study, including melanomas with small cell/nevoid subpopulations (MSCN) or melanomas with pre-existing nevus (MPEN). Semiquantitative and computer-validated immunohistochemical analyses revealed invariable, uniform loss of 5-hmC in the conventional melanoma component. By contrast, the nevic components in MPEN cases demonstrated strong nuclear immunopositivity. In MSCN cases, there was partial to complete loss of 5-hmC restricted to these nevoid areas. Based on recent data supporting tight correlation between 5-hmC loss and malignancy, our findings indicate a potential 'intermediate' biological nature for small cell/nevoid subpopulations. Because 5-hmC assisted in differentiating such regions from associated nevus, the use of 5-hmC as an adjunct to microstaging in difficult cases showing VGP heterogeneity should be further explored.Citation
Loss of the epigenetic mark, 5-Hydroxymethylcytosine, correlates with small cell/nevoid subpopulations and assists in microstaging of human melanoma. 2015: OncotargetJournal
OncotargetPubMed ID
26462027Type
ArticleLanguage
enISSN
1949-2553Collections
Related articles
- Diagnostic utility of 5-hydroxymethylcytosine immunohistochemistry in melanocytic proliferations.
- Authors: Rodić N, Zampella J, Sharma R, Burns KH, Taube JM
- Issue date: 2015 Nov
- Fluorescence in situ hybridization as a tool for microstaging in malignant melanoma.
- Authors: Newman MD, Lertsburapa T, Mirzabeigi M, Mafee M, Guitart J, Gerami P
- Issue date: 2009 Aug
- 5-Hydroxymethylcytosine Expression in Proliferative Nodules Arising within Congenital Nevi Allows Differentiation from Malignant Melanoma.
- Authors: Pavlova O, Fraitag S, Hohl D
- Issue date: 2016 Dec
- Morphologic clues and utility of fluorescence in situ hybridization for the diagnosis of nevoid melanoma.
- Authors: Yélamos O, Busam KJ, Lee C, Meldi Sholl L, Amin SM, Merkel EA, Obregon R, Guitart J, Gerami P
- Issue date: 2015 Nov
- Diagnostic utility of dual 5-hydroxymethylcytosine/Melan-A immunohistochemistry in differentiating nodal nevus from metastatic melanoma: An effective first-line test for the workup of sentinel lymph node specimen.
- Authors: Siref AB, Huynh CAT, Balzer BL, Frishberg DP, Essner R, Shon W
- Issue date: 2019 Apr